Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Price finding solid support around 1.30. Traveling just below 50MA. Should make a move up towards 200MA and potential gap fill at 1.50+
Pulmatrix Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables...
This drug company with lung inhaler administered medicine appears to have bottomed and is moving some. Being bought by Armistice Hedge fund. I can wait. Targets will provide 3x and 10x approx.
Looking for continuation and possible breakout today in PULM Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its...
Alert set for break above $1.90 for potential breakout Strong RSi and MACD
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which...
Hello Everyone, The stock (PULM) experienced rapid growth (bull) within today's market. Considering the current sporadic momentum upwards, there is none-the-less an opportunity to short the stock till price consolidation. Resistance Level 1 - (4.30 - 4.50) 20 pip interval Blue Horizontal Line - (1.80 - 2.10) 30 pip interval Support Level 1 - (0.50 - 0.80) 30...
Pulmatrix Drug Candidate Receives "Qualified Infectious Disease Product" (QIDP) Designation from the FDA The FDA designation adds five years of market exclusivity for Pulmatrix' inhaled product for treating fungal infections in the lungs of CF patients Under the QIDP program, which is designed to speed the development of novel drugs against important pathogens,...
PULM is setting up for a good short term swing. Long term might be a little risky since SEC PRE-14A will have a June 2018 vote for a RSI proxy vote.
the 1.618 of the highlighted trend. bullish and bearish
been watching pulm for continuation and we have nice volume confirmation on the pivots with breakout, retesting breakout line and 50dma stock should go higher